Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FASTEST Part 2
NCT07227246Phase 3Recruiting
- Start
- May 2025
- Primary completion
- Jan 2029
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 6
01
Overview
A Phase 3 trial of coagulation factor VIIa in intracerebral hemorrhage (ICH). Started May 2025; status: recruiting.
02
Drugs
coagulation factor VIIa
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT07227246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07227246.